Associated Papers
Caveolin and NOS in the Development of Muscular Dystrophy.
Nakashima M et al.
International Journal of Molecular Sciences, 2024
Genetics and Autoimmunity: Two Sides of the Same Coin or an Epiphenomenon?
Chatterjee R et al.
Mediterranean Journal of Rheumatology, 2022
The role of CAV3 in long-QT syndrome: clinical and functional assessment of a caveolin-3/Kv11.1 double heterozygote versus caveolin-3 single heterozygote.
Hedley PL et al.
Circulation. Cardiovascular Genetics, 2013
Caveolinopathies: from the biology of caveolin-3 to human diseases.
Gazzerro E et al.
European Journal of Human Genetics : Ejhg, 2010
Rippling muscle disease: variable phenotype in a family with five afflicted members.
Jacobi C et al.
Muscle & Nerve, 2010
Chronic ophthalmoparesis in limb girdle muscular dystrophy 1C.
Filosto M et al.
Journal of Neurology, Neurosurgery, and Psychiatry, 2009
Molecular and muscle pathology in a series of caveolinopathy patients.
Fulizio L et al.
Human Mutation, 2005
Limb-girdle muscular dystrophy in a 71-year-old woman with an R27Q mutation in the CAV3 gene.
Figarella-Branger D et al.
Neurology, 2003
Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency.
Minetti C et al.
The American Journal of Pathology, 2002
Select a paper to view details